Literature DB >> 21737453

Expression of truncated eukaryotic initiation factor 3e (eIF3e) resulting from integration of mouse mammary tumor virus (MMTV) causes a shift from cap-dependent to cap-independent translation.

David Chiluiza1, Sharon Bargo, Robert Callahan, Robert E Rhoads.   

Abstract

Integration of mouse mammary tumor virus (MMTV) at the common integration site Int6 occurs in the gene encoding eIF3e, the p48 subunit of translation initiation factor eIF3. Integration is at any of several introns of the Eif3e gene and causes the expression of truncated Eif3e mRNAs. Ectopic expression of the truncated eIF3e protein resulting from integration at intron 5 (3e5) induces malignant transformation, but by an unknown mechanism. Because eIF3e makes up at least part of the binding site for eIF4G, we examined the effects of 3e5 expression on protein synthesis. We developed an NIH3T3 cell line that contains a single copy of the 3e5 sequence at a predetermined genomic site. Co-immunoprecipitation indicated diminished binding of eIF3 to eIF4G, signifying a reduction in recruitment of the mRNA-unwinding machinery to the 43 S preinitiation complex. Cell growth and overall protein synthesis were decreased. Translation driven by the eIF4G-independent hepatitis C virus internal ribosome entry sequence (HCV IRES) in a bicistronic mRNA was increased relative to cap-dependent translation. Endogenous mRNAs encoding XIAP, c-Myc, CYR61, and Pim-1, which are translated in a cap-independent manner, were shifted to heavier polysomes whereas mRNAs encoding GAPDH, actin, L32, and L34, which are translated in a cap-dependent manner, were shifted to lighter polysomes. We propose that expression of 3e5 diminishes eIF4G interaction with eIF3 and causes abnormal gene expression at the translational level. The correlation between up-regulation of cap-independent translation and MMTV-induced tumorigenesis contrasts with the well established model for malignant transformation involving up-regulation of highly cap-dependent translation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737453      PMCID: PMC3173083          DOI: 10.1074/jbc.M111.267294

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Evidence for the transforming activity of a truncated Int6 gene, in vitro.

Authors:  S B Rasmussen; E Kordon; R Callahan; G H Smith
Journal:  Oncogene       Date:  2001-08-30       Impact factor: 9.867

2.  Mutually cooperative binding of eukaryotic translation initiation factor (eIF) 3 and eIF4A to human eIF4G-1.

Authors:  N L Korneeva; B J Lamphear; F L Hennigan; R E Rhoads
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

3.  Association of the mammalian proto-oncoprotein Int-6 with the three protein complexes eIF3, COP9 signalosome and 26S proteasome.

Authors:  Karine Hoareau Alves; Valérie Bochard; Stéphane Réty; Pierre Jalinot
Journal:  FEBS Lett       Date:  2002-09-11       Impact factor: 4.124

4.  A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection.

Authors:  M Holcik; C Lefebvre; C Yeh; T Chow; R G Korneluk
Journal:  Nat Cell Biol       Date:  1999-07       Impact factor: 28.824

5.  Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment.

Authors:  M Stoneley; T Subkhankulova; J P Le Quesne; M J Coldwell; C L Jopling; G J Belsham; A E Willis
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

6.  Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e).

Authors:  Greg L Mayeur; John W B Hershey
Journal:  FEBS Lett       Date:  2002-03-06       Impact factor: 4.124

7.  Reduced expression of INT-6/eIF3-p48 in human tumors.

Authors:  A Marchetti; F Buttitta; S Pellegrini; G Bertacca; R Callahan
Journal:  Int J Oncol       Date:  2001-01       Impact factor: 5.650

8.  L-Myc protein synthesis is initiated by internal ribosome entry.

Authors:  Catherine L Jopling; Keith A Spriggs; Sally A Mitchell; Mark Stoneley; Anne E Willis
Journal:  RNA       Date:  2004-02       Impact factor: 4.942

9.  Generation of multiple isoforms of eukaryotic translation initiation factor 4GI by use of alternate translation initiation codons.

Authors:  Marshall P Byrd; Miguel Zamora; Richard E Lloyd
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 10.  The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.

Authors:  J A Menéndez; I Mehmi; D W Griggs; R Lupu
Journal:  Endocr Relat Cancer       Date:  2003-06       Impact factor: 5.678

View more
  12 in total

1.  Tumor suppressor PDCD4 represses internal ribosome entry site-mediated translation of antiapoptotic proteins and is regulated by S6 kinase 2.

Authors:  Urszula Liwak; Nehal Thakor; Lindsay E Jordan; Rajat Roy; Stephen M Lewis; Olivier E Pardo; Michael Seckl; Martin Holcik
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

2.  Elevated levels of ribosomal proteins eL36 and eL42 control expression of Hsp90 in rhabdomyosarcoma.

Authors:  Sarah Shaikho; Christine C Dobson; Thet Naing; Bahram Samanfar; Houman Moteshareie; Maryam Hajikarimloo; Ashkan Golshani; Martin Holcik
Journal:  Translation (Austin)       Date:  2016-10-04

Review 3.  eIF3: a factor for human health and disease.

Authors:  Andreia Gomes-Duarte; Rafaela Lacerda; Juliane Menezes; Luísa Romão
Journal:  RNA Biol       Date:  2017-11-13       Impact factor: 4.652

4.  Activation of Pim Kinases Is Sufficient to Promote Resistance to MET Small-Molecule Inhibitors.

Authors:  Ningfei An; Ying Xiong; Amanda C LaRue; Andrew S Kraft; Bo Cen
Journal:  Cancer Res       Date:  2015-12-15       Impact factor: 12.701

5.  Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC.

Authors:  Gillian Moore; Clara Lightner; Samira Elbai; Lauren Brady; Siobhan Nicholson; Ronan Ryan; Katie E O'Sullivan; Kenneth J O'Byrne; Carmen Blanco-Aparicio; Sinead Cuffe; Michael O'Neill; Susan Heavey; Stephen P Finn; Kathy Gately
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

6.  Up-regulation Of EIF3e Is Associated with The Progression of Esophageal Squamous Cell Carcinoma and Poor Prognosis in Patients.

Authors:  Fengkai Xu; Jie Gu; Lin Wang; Ronghua Liu; Yunfeng Yuan; Hao Wang; Jiahao Jiang; Wei Mao; Chunlai Lu; Di Ge
Journal:  J Cancer       Date:  2018-03-08       Impact factor: 4.207

7.  Coupling 40S ribosome recruitment to modification of a cap-binding initiation factor by eIF3 subunit e.

Authors:  Derek Walsh; Ian Mohr
Journal:  Genes Dev       Date:  2014-04-15       Impact factor: 11.361

8.  Embraced by eIF3: structural and functional insights into the roles of eIF3 across the translation cycle.

Authors:  Leoš Shivaya Valášek; Jakub Zeman; Susan Wagner; Petra Beznosková; Zuzana Pavlíková; Mahabub Pasha Mohammad; Vladislava Hronová; Anna Herrmannová; Yaser Hashem; Stanislava Gunišová
Journal:  Nucleic Acids Res       Date:  2017-11-02       Impact factor: 16.971

Review 9.  Regulation of Epithelial-to-Mesenchymal Transition by Alternative Translation Initiation Mechanisms and Its Implications for Cancer Metastasis.

Authors:  Amit Bera; Stephen M Lewis
Journal:  Int J Mol Sci       Date:  2020-06-07       Impact factor: 5.923

10.  Eukaryotic translation initiation factor 3 (eIF3) subunit e is essential for embryonic development and cell proliferation.

Authors:  Daichi Sadato; Tomio Ono; Saki Gotoh-Saito; Naoki Kajiwara; Namiko Nomura; Masako Ukaji; Liying Yang; Kenji Sakimura; Youichi Tajima; Keisuke Oboki; Futoshi Shibasaki
Journal:  FEBS Open Bio       Date:  2018-07-05       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.